Best Momentum Stock to Buy for December 31st
ULTA, PATH and SLDE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 31, 2025.
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
UiPath Stock Pops After S&P MidCap 400 Promotion
UiPath Inc. (NYSE:PATH) shares are up 5.6% to trade at $16.81 at last check, following news the software company will join the S&P MidCap 400 before the open on Thursday, Jan. 2.
A Software Stock Is Joining a MidCap Index. Its 2025 Climb Is Continuing
Shares of UiPath rose Wednesday on news that the business software company will join the S&P MidCap 400 Index.
UiPath to be added to S&P MidCap 400, shares jump
UiPath Inc (NYSE:PATH) shares jumped 6% on the news that the automation platform will be added to the S&P MidCap 400 prior to the opening of trading on January 2, replacing Synovus Financial. The change follows an agreement under which S&P MidCap 400 constituent Pinnacle Financial Partners is acquiring Synovus Financial in a transaction expected to close soon, subject to final closing conditions.
UiPath Stock Is Surging. Why the AI Winner Is Getting a Big Boost.
The automation software company looks like a potential winner from the AI boom, with shares up 26% in 2025.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath: Finally Gaining Recognition It Deserves - Wait For A Dip-Buying Opportunity
UiPath's deep-value thesis plays out beyond my expectations, as observed in the high-double digit rally from the recent bottoms and the fair valuations. Its new partnerships with OpenAI, Google, Nvidia, and Snowflake position it for expanded adoption and growth re-acceleration from FY2027 onwards. PATH's renewed growth opportunities are well supported by the accelerating ARR growth, the improving operating leverage, and the early stage of its agentic AI monetization.
UiPath Soars 51% in Three Months: Accumulate Now or Wait for a Pause?
PATH shares are up 51% in three months as agentic AI adoption accelerates, lifting deal sizes, margins and confidence in UiPath's automation growth story.
UiPath: The Agentic AI Pivot Is Real. Why I Am Still Buying
PATH is transitioning from an RPA provider to a leading agent AI platform, underpinned by strategic partnerships with Snowflake, Google, Microsoft, and Nvidia. PATH possesses every capability to take one of the leading positions in the field of AI-Agent solutions, and there are fundamental and strategic reasons for this. We analyze the results for the third quarter and assess the potential risks.
UIPath: This Is Not The AI Or Robotics Stock To Buy Now
UIPath has rebounded approximately 75% from recent lows but remains far below its 2021 IPO peak. PATH is a software company focused on robotic process automation. There is spirited debate as to its positioning amid the current AI transformation. The company has delivered consistent but fairly modest growth in recent years.
UiPath: One Of The Few Agentic AI Stocks Still Trading Cheaply
UiPath has successfully integrated generative AI into its RPA platform, reigniting growth and customer traction. PATH achieved 11% YoY ARR growth and positive GAAP operating income, with management now committed to sustained GAAP profitability. PATH trades at less than 6x forward sales which looks compelling given the profitability outlook.
